Literature DB >> 18165706

Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis.

Hamid Mahmoudzadeh-Niknam1, Simin Sadat Kiaei, Davood Iravani.   

Abstract

Leishmania (L.) tropica is a causative agent of cutaneous leishmaniasis, and occasionally of visceral or viscerotropic leishmaniasis in humans. Murine models of Leishmania infection have been proven to be useful for elucidation of mechanisms for pathogenesis and immunity in leishmaniasis. The aim of this study was to establish a murine model for human viscerotropic leishmaniasis, and the growth pattern of L. tropica was studied in different tissues of BALB/c mice in order to find out whether the parasite visceralizes in this murine model. L. major was used as a control as this species is known to cause a progressive infection in BALB/c mice. L. tropica or L. major was injected into the footpad of mice, and thickness of footpad, parasite loads in different tissues, and the weight of the spleen and lymph node were determined at different intervals. Results showed that L. tropica visceralizes to the spleen and grows there while its growth is controlled in footpad tissues. Dissemination of L. tropica to visceral organs in BALB/c mice was similar to the growth patterns of this parasite in human viscerotropic leishmaniasis. The BALB/c model of L. tropica infection may be considered as a good experimental model for human diseases.

Entities:  

Mesh:

Year:  2007        PMID: 18165706      PMCID: PMC2532621          DOI: 10.3347/kjp.2007.45.4.247

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  20 in total

Review 1.  Advances in leishmaniasis.

Authors:  Henry W Murray; Jonathan D Berman; Clive R Davies; Nancy G Saravia
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

Review 2.  The immunology of susceptibility and resistance to Leishmania major in mice.

Authors:  David Sacks; Nancy Noben-Trauth
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

Review 3.  Immunopathogenesis of infection with the visceralizing Leishmania species.

Authors:  Mary E Wilson; Selma M B Jeronimo; Richard D Pearson
Journal:  Microb Pathog       Date:  2005-04       Impact factor: 3.738

4.  Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody.

Authors:  María Colmenares; Stephanie L Constant; Peter E Kima; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.

Authors:  C R Engwerda; M L Murphy; S E Cotterell; S C Smelt; P M Kaye
Journal:  Eur J Immunol       Date:  1998-02       Impact factor: 5.532

6.  Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.

Authors:  Hamid Mahmoudzadeh-Niknam; Simin Sadat Kiaei; Davood Iravani
Journal:  Korean J Parasitol       Date:  2007-06       Impact factor: 1.341

Review 7.  Leishmania tropica (Kinetoplastida: Trypanosomatidae)--a perplexing parasite.

Authors:  Raymond L Jacobson
Journal:  Folia Parasitol (Praha)       Date:  2003-12       Impact factor: 2.122

8.  Leishmania tropica: cysteine proteases are essential for growth and pathogenicity.

Authors:  H Mahmoudzadeh-Niknam; J H McKerrow
Journal:  Exp Parasitol       Date:  2004 Mar-Apr       Impact factor: 2.011

9.  Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran.

Authors:  Abdolvahab Alborzi; Manoochehr Rasouli; Ahmad Shamsizadeh
Journal:  Am J Trop Med Hyg       Date:  2006-02       Impact factor: 2.345

10.  Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease.

Authors:  R Lira; S Méndez; L Carrera; C Jaffe; F Neva; D Sacks
Journal:  Exp Parasitol       Date:  1998-07       Impact factor: 2.011

View more
  7 in total

1.  Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.

Authors:  Mosayeb Rostamian; Davood Jafari; Maryam Abolghazi; Hadiseh Farahani; Hamid M Niknam
Journal:  Parasitol Res       Date:  2018-07-05       Impact factor: 2.289

2.  Leishmanicidal Activity of Piper nigrum Bioactive Fractions is Interceded via Apoptosis In Vitro and Substantiated by Th1 Immunostimulatory Potential In Vivo.

Authors:  Garima Chouhan; Mohammad Islamuddin; Muzamil Y Want; Hani A Ozbak; Hassan A Hemeg; Dinkar Sahal; Farhat Afrin
Journal:  Front Microbiol       Date:  2015-12-08       Impact factor: 5.640

3.  Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo.

Authors:  Farhat Afrin; Garima Chouhan; Mohammad Islamuddin; Muzamil Y Want; Hani A Ozbak; Hassan A Hemeg
Journal:  PLoS Negl Trop Dis       Date:  2019-05-09

4.  The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c mice.

Authors:  Hamid Mahmoudzadeh-Niknam; Ghader Khalili; Firoozeh Abrishami; Ali Najafy; Vahid Khaze
Journal:  Korean J Parasitol       Date:  2013-02-18       Impact factor: 1.341

5.  Polymerase chain reaction detection and inducible nitric-oxide synthase expression of Leishmania major in mice inoculated by two different routes.

Authors:  Abeer E Mahmoud; Rasha Ah Attia; Hanan Em Eldeek; Haiam Mohammed Mahmoud Farrag; Rania Makboul
Journal:  Trop Parasitol       Date:  2016 Jan-Jun

6.  Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology.

Authors:  Naouel Eddaikra; Ihcene Kherachi Djenad; Sihem Benbetka; Razika Benikhlef; Khatima Aït-Oudhia; Farida Moulti-Mati; Bruno Oury; Denis Sereno; Zoubir Harrat
Journal:  Biomed Res Int       Date:  2016-02-02       Impact factor: 3.411

7.  Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice.

Authors:  Mosayeb Rostamian; Fariborz Bahrami; Hamid M Niknam
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.